Global Digital Pathology Systems Industry Market Research Report
Reportlinker.com announces that a new market research report is available in its catalogue:
Global Digital Pathology System Industry Report
This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million.
The report provides separate comprehensive analytics for the US, Canada, Japan,Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million.
The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., and VMscope GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. ECUTIVE SUMMARY
1. OUTLOOK II-1
A Prelude II-1
Current & Future Analysis II-1
Key Trends and Drivers II-2
Challenges Ahead for Digital Pathology Systems II-2
2. INDUSTRY OVERVIEW II-3
Traditional Pathology Workflow – A Cumbersome Process Laced
with Issues II-3
The Evolution of Digital Pathology Systems II-3
Digital Pathology Products and Procedures II-4
Digital Pathology as a Service Eludes Cost-based Issues II-4
Applications of Digital Pathology and the Need for a
Management System II-5
Digital Pathology in Treatment of Cancer and Other Diseases II-5
Digital Pathology in the Clinical Research Scenario II-5
Telepathology Expected to Pave Way for Pathology Outsourcing
to Developing Nations II-6
Cloud Hosting and Web-based Applications Offer Cost-Effective
Digital Pathology Options II-6
A Review of Information Archival and Retrieval in Digital
Pathology II-6
Storage and Interoperability II-7
Location and Internal Communication II-7
Systems and Data Reliability II-7
Image Life-Cycle Management II-8
IT infrastructure and Management Costs II-8
Factors Affecting Information Archival II-8
3. COMPETITION II-9
Leading Players II-9
Table 1: Leading Players in the Global Digital Pathology
Systems Market (2012): Percentage Breakdown of Dollar Sales
for Leica/Aperio, Ventana, Olympus and Others (includes
corresponding Graph/Chart) II-9
Consolidation Rife in the Digital Pathology Space II-9
Leica’s Acquisition of Aperio – The Underlying Rationale II-10
4. PRODUCT OVERVIEW II-11
An Introduction to Pathology II-11
What is Digital Pathology? II-11
Benefits of Digital Pathology II-11
Access to Digital Slide Images Anytime Anywhere II-12
Digital Pathology Management Systems II-12
Easier Analysis and Retrieval of Digital Images II-12
Applications II-13
Remote Reviewing II-13
Digital-Assisted Mathematical Analysis II-13
Data Storage II-13
Telepathology II-13
Static Telepathology II-14
Dynamic Telepathology II-14
Hybrid Telepathology II-14
Bio-banking II-14
Multinational Integration II-14
Tissue Microarray Analysis II-15
5. PRODUCT INTRODUCTIONS/INNOVATIONS II-16
Ventana Medical Systems Launches iScan HT Slide Scanner II-16
Aperio Technologies Introduces Release 11.0 of Digital
Pathology System II-16
Omnyx Showcases Upcoming Integrated Digital Pathology Solution II-16
Pixcelldata Unveils Collibio Desktop Version II-17
Carl Zeiss MicroImaging Launches LSM 700 Microscope II-17
Agfa Healthcare Unveils Integrated Digital Pathology Solution II-17
Leica Microsystems Expands Capabilities of Leica SCN400 and
SCN400 F Scanners II-18
Omnyx Unveils Omnyx™ VL4 Scanner to Beta Consumers II-18
Leica Microsystems Launches Total Digital Pathology Solution II-19
Definiens® Unveils Quantitative Digital Pathology Portfolio II-19
Aperio Technologies Introduces ScanScope AT Pathology Slide
Scanner II-20
MikroScan Technologies Unveils MikroScan D2 Slide Imaging Scanner II-20
Caliper® Life Sciences Introduces Vectra™ 2 with AQUA
Technology for Quantification of Protein Biomarkers II-21
Philips to Introduce Digital Pathology Technology II-21
BioImagene Launches Digital Pathology Solutions in Europe II-21
BioImagene Unveils Next Generation Virtuoso™ and iScan Coreo
Au Slide Scanner II-21
Definiens Develops Novel Software Application II-22
MikroScan Technologies Unveils New Product Range II-22
Aperio Technologies Unveils Discover Your Path Assessment
Program for Hospitals II-23
CBLPath Introduces Best Practice™ Partnership Program II-23
Nikon Instruments Launches Mi Macro Imaging Grossing Station II-23
Definiens Introduces Definiens Tissue Studio II-24
BioImagene Introduces Crescendo DPW II-24
Aperio Technologies Introduces Clinical Partner Service Program II-24
Targeted Molecular Diagnostics Introduces Digital Pathology
Services in China II-25
Applied Spectral Imaging Launches PathEx Duo Detection System II-25
Aperio Technologies Launches Digital IHC Solution II-25
Visuvi and BioImagene Launch PathSearch™ II-26
Amirsys Integrates PathIQ ImmunoQuery with Virtuoso of BioImagene II-26
6. RECENT INDUSTRY ACTIVITY II-27
Leica Biosystems Takes Over Aperio Technologies II-27
Carl Zeiss MicroImaging and Olympus America Sign Licensing
Agreement II-27
Aperio Technologies and Dell Enter into Strategic Collaboration II-28
Erasmus MC Selects Philips to Adopt Digital Pathology System II-28
Leica Microsystems and Indica Labs Sign Agreement II-28
Ventana Medical Systems Obtains USFDA 510(k) Clearance for
VENTANA Companion Algorithm Ki-67 (30-9) Image Analysis
Solution II-28
AccelPath Acquires DigiPath Solutions II-29
Omnyx™ Receives CE Mark in Europe II-29
XStor Systems and Quorum Technologies Enter Into Distribution
Partnership II-29
Royal Philips Electronics and NEC Ink Agreement II-30
GE Healthcare Enters into Partnership with Singapore General
Hospital II-30
PathXL Enters into Partnership with Visiopharm II-31
Aperio Technologies Enters into Partnership with Definiens to
Market Definiens Tissue Studio™ II-31
Caliper Life Sciences Takes Over CRi II-32
Ventana Medical Systems Takes Over BioImagene II-32
Leica Microsystems Acquires Genetix II-32
Dartmouth-Hitchcock Medical Center to Deploy BioImagene Solutions II-33
Royal Philips Electronics Ink Cooperation Agreement with
Definiens II-33
UPMC and GE Healthcare Enter into Joint Venture II-33
i-Path Diagnostics and iSOFT Group to Enter into Partnership II-34
KUMC and BioImagene Enter into Collaboration II-34
CRi and 3DHISTECH Ink Exclusive Agreements II-34
BioImagene and LigoLab Develop New Interface II-35
Olympus America and Omnyx Ink Nonexclusive Global Licensing
Agreement II-35
Aperio Technologies and ADCIS Enter into Partnership II-35
VMscope and Pixcelldata Enter into Partnership II-36
Aperio Technologies Receives Patent from United States Patent
and Trademark Office II-36
Royal Philips Electronics and Dako Ink Agreement II-36
Dako Signs Agreement with Omnyx II-37
Flagship Biosciences Inks Service Partnership with Expression
Pathology II-37
Flagship Biosciences Establishes Digital Pathology office in
Boston Suburbs II-38
Omnyx to Commence Clinical Research Testing of Omnyx
Integrated Digital Pathology Solution II-38
Henry Ford Health System to Deploy PathPACS® of Apollo PACS II-38
Genetix Takes Over SlidePath II-39
Omnyx Receives Patent from US Patent and Trademark Office II-39
7. FOCUS ON SELECT GLOBAL PLAYERS II-40
3DHISTECH Ltd. (Hungary) II-40
AccelPath, Inc. (US) II-40
Apollo PACS, Inc. (US) II-41
Carl Zeiss MicroImaging GmbH (Germany) II-41
Corista LLC (US) II-42
Definiens AG (Germany) II-42
DigiPath Inc. (US) II-42
Flagship Biosciences, LLC (US) II-43
Koninklijke Philips Electronics N.V. (Netherlands) II-43
Leica Microsystems GmbH (Germany) II-44
Aperio Technologies, Inc. (US) II-44
MikroScan Technologies, Inc. (US) II-45
Olympus America, Inc. (US) II-45
Omnyx, LLC (US) II-46
Pixcelldata Ltd. (Ireland) II-46
Ventana Medical Systems, Inc. (US) II-46
BioImagene, Inc. (US) II-47
VMscope GmbH (Germany) II-47
8. GLOBAL MARKET PERSPECTIVE II-48
Table 2: World Recent Past, Current and Future Analysis for
Digital Pathology Systems by Geographic Region – US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Revenues in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-48
Table 3: World Historic Review for Digital Pathology Systems
by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) II-49
Table 4: World 15-Year Perspective for Digital Pathology
Systems by Geographic Region – Percentage Breakdown of
Revenues for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets for Years 2004,
2012, and 2018 (includes corresponding Graph/Chart) II-50
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Regulatory Scenario in the US III-1
Health Insurance Portability and Accountability Act (HIPAA) III-1
Food and Drug Administration (FDA) III-1
Clinical Laboratory Improvement Amendments (CLIA) III-1
Product Launches III-2
Strategic Corporate Developments III-8
Key Players III-16
B.Market Analytics III-22
Table 5: US Recent Past, Current and Future Analysis for
Digital Pathology Systems with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-22
Table 6: US Historic Review for Digital Pathology Systems
with Annual Revenues in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-23
2. CANADA III-24
A.Market Analysis III-24
Current & Future Analysis III-24
Need for Digital Pathology in Canada III-24
Strategic Corporate Development III-24
B.Market Analytics III-25
Table 7: Canadian Recent Past, Current and Future Analysis
for Digital Pathology Systems with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-25
Table 8: Canadian Historic Review for Digital Pathology
Systems with Annual Revenues in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-26
3. JAPAN III-27
Market Analysis III-27
Table 9: Japanese Recent Past, Current and Future Analysis
for Digital Pathology Systems with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-27
Table 10: Japanese Historic Review for Digital Pathology
Systems with Annual Revenues in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-28
4. EUROPE III-29
A.Market Analysis III-29
Current & Future Analysis III-29
Product Launches III-29
Strategic Corporate Developments III-33
Key Players III-37
B.Market Analytics III-41
Table 11: European Recent Past, Current and Future Analysis
for Digital Pathology Systems by Country/Region – France,
Germany, Italy, UK, Spain, and Rest of Europe Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-41
Table 12: European Historic Review for Digital Pathology
Systems by Country/Region – France, Germany, Italy, UK,
Spain, and Rest of Europe Markets Independently Analyzed
with Annual Revenues in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-42
Table 13: European 15-Year Perspective for Digital Pathology
Systems by Country/Region – Percentage Breakdown of Revenues
for France, Germany, Italy, UK, Spain and Rest of Europe
Markets for Years 2004, 2012, and 2018 (includes
corresponding Graph/Chart) III-43
5. ASIA-PACIFIC III-44
A.Market Analysis III-44
Current & Future Analysis III-44
Product Launch III-44
Strategic Corporate Development III-44
B.Market Analytics III-45
Table 14: Asia-Pacific Recent Past, Current and Future
Analysis for Digital Pathology Systems with Annual Revenues
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-45
Table 15: Asia-Pacific Historic Review for Digital Pathology
Systems with Annual Revenues in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-46
6. REST OF WORLD III-47
A.Market Analysis III-47
Current & Future Analysis III-47
Product Launch III-47
B.Market Analytics III-48
Table 16: Rest of World Recent Past, Current and Future
Analysis for Digital Pathology Systems with Annual Revenues
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-48
Table 17: Rest of World Historic Review for Digital
Pathology Systems with Annual Revenues in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-49
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries – 51)
The United States (30)
Canada (3)
Japan (2)
Europe (15)
– Germany (6)
– The United Kingdom (1)
– Spain (1)
– Rest of Europe (7)
Asia-Pacific (Excluding Japan) (1)
